Related Experiment Video
Updated: Mar 15, 2026

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
Published on: December 7, 2014
Novel compound heterozygous mutations in a Japanese girl with Janus kinase 3 deficiency
Takeshi Sato1, Tsubasa Okano1, Mari Tanaka-Kubota1
1Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan.
Abstract:
Severe combined immunodeficiency (SCID) is the most severe form of primary immunodeficiency disease, and it is characterized by marked impairment in cellular and humoral immunity. Mutations in several genes cause SCID, one of which is Janus kinase 3 (JAK3), resulting in autosomal recessive T(-)B(+)NK(-) SCID. Only three patients with JAK3-deficient SCID have been reported in Japan. We herein describe the case of a 6-month-old girl with pneumocystis pneumonia, who was diagnosed with SCID with compound heterozygous JAK3 mutations (c.1568G>A + c.421-10G>A). One of the mutations was previously reported in another Japanese patient. The other mutation was a novel and de novo relatively deep intronic mutation causing aberrant RNA splicing. The patient was successfully treated with bone marrow transplantation from a haploidentical donor.
Related Concept Videos
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Pleiotropy
cAMP-dependent Protein Kinase Pathways
TGF - β Signaling Pathway
Cardiomyopathy III: Hypertrophic Cardiomyopathy

